TY - JOUR
A1 - Ozcelikay, Goksu
A1 - Kurbanoglu, Sevinc
A1 - Yarman, Aysu
A1 - Scheller, Frieder W.
A1 - Ozkan, Sibel A.
T1 - Au-Pt nanoparticles based molecularly imprinted nanosensor for electrochemical detection of the lipopeptide antibiotic drug Daptomycin
JF - Sensors and actuators : B, Chemical
N2 - In this work, a novel electrochemical molecularly imprinted polymer (MIP) sensor for the detection of the lipopeptide antibiotic Daptomycin (DAP) is presented which integrates gold decorated platinum nanoparticles (Au-Pt NPs) into the nanocomposite film. The sensor was prepared by electropolymerization of o-phenylenediamine (o-PD) in the presence of DAP using cyclic voltammetry. Cyclic voltammetry and differential pulse voltammetry were applied to follow the changes in the MIP-layer related to rebinding and removal of the target DAP by using the redox marker [Fe(CN)(6)](3-/4-). Under optimized operational conditions, the MIP/Au-Pt NPs/ GCE nanosensor exhibits a linear response in the range of 1-20 pM towards DAP. The limit of detection and limit of quantification were determined to be 0.161pM +/- 0.012 and 0.489pM +/- 0.012, respectively. The sensitivity towards the antibiotics Vancomycin and Erythromycin and the amino acids glycine and tryptophan was below 7 percent as compared with DAP. Moreover, the nanosensor was also successfully used for the detection of DAP in deproteinated human serum samples.
KW - molecularly imprinted polymer
KW - Daptomycin
KW - platinum nanoparticles
KW - gold
KW - nanoparticles
KW - modified electrodes
Y1 - 2020
U6 - https://doi.org/10.1016/j.snb.2020.128285
SN - 0925-4005
VL - 320
PB - Elsevier Science
CY - Amsterdam
ER -
TY - JOUR
A1 - Kurbanoglu, Sevinc
A1 - Yarman, Aysu
T1 - Simultaneous determination of hydrochlorothiazide and irbesartan from pharmaceutical dosage forms with RP-HPLC
T1 - Farmasötik Dozaj Formlarında TF-YPSK ile Hidroklorotiyazid ve
İrbesartanın Eş Zamanlı Tayini
JF - Turkish journal of pharmaceutical sciences
N2 - Objectives: In this work, a simple and rapid liquid chromatographic method for the simultaneous determination of irbesartan (IRBE) and hydrochlorothiazide (HCT) was developed and validated by reverse phase high performance liquid chromatography (RP-HPLC).
Materials and Methods: Experimental conditions such as different buffer solutions, various pH values, temperature, composition of the mobile phase, and the effect of flow rate were optimized.
Results: The developed RP-HPLC method for these antihypertensive agents was wholly validated and IRBE was detected in the linear range of 0.1-25 mu g mL(-1) and HCT was detected in the linear range of 0.25-25 mu g mL(-1). Moreover, the suggested chromatographic technique was successfully applied for the determination of the drugs in human serum and pharmaceutical dosage forms with limit of detection values of 0.008 mu g mL(-1) for IRBE and 0.012 mu g mL(-1) for HCT.
Conclusion: The proposed rapid analysis method of these antihypertensive drugs can be easily used and applied by pharmaceutical companies for which the analysis time is important.
N2 - Amaç: Bu çalışmada, irbesartan (IRBE) ve hidroklorotiyazidin (HCT) eşzamanlı tayini için basit ve hızlı bir ters fazlı yüksek performanslı sıvı
kromatografisi (TF-YPSK) yöntemi geliştirilmiş ve validasyon çalışmaları yapılmıştır.
Gereç ve Yöntemler: Deneysel koşullar; farklı tampon çözeltileri, çeşitli pH değerleri, sıcaklık, mobil fazın bileşimi, akış hızının etkisi gibi
parametrelerin üzerinden optimize edildi.
Bulgular: Bu antihipertansif ajanlar için geliştirilen TF-YPSK yönteminin tüm validasyon parametrelerine ilişkin çalışmalar yapılmış, ve IRBE 0,1-25
μg mL-1 doğrusal aralığında ve HCT 0,25-25 μg mL-1 doğrusal aralığında tespit edilmiştir. Ayrıca önerilen TF-YPSK yöntemi ile IRBE için 0,008 μg
mL-1 ve HCT için 0,012 μg mL-1 tayin alt sınır değerleri bulunmuştur. Geliştirilen yöntem, insan serumunda ve farmasötik dozaj formlarında bulunan
IRBE ve HCT’nin belirlenmesi için başarıyla uygulanmıştır.
Sonuç: Bu antihipertansif ilaçların miktar tayininde önerilen YPSK analiz yönteminin, analiz süresinin önemli olduğu ilaç firmalarında rahatlıkla
kullanılabileceği ve uygulanabileceği düşünülmektedir.
KW - HPLC
KW - irbesartan
KW - hydrochlorothiazide
KW - pharmaceutical dosage forms
Y1 - 2020
U6 - https://doi.org/10.4274/tjps.galenos.2019.76094
SN - 1304-530X
VL - 17
IS - 5
SP - 523
EP - 527
PB - Turkish Pharmacists Association
CY - Çankaya-Ankara
ER -
TY - JOUR
A1 - Ozcelikay, Goksu
A1 - Kurbanoglu, Sevinc
A1 - Zhang, Xiaorong
A1 - Söz, Çağla Kosak
A1 - Wollenberger, Ulla
A1 - Ozkan, Sibel A.
A1 - Yarman, Aysu
A1 - Scheller, Frieder W.
T1 - Electrochemical MIP Sensor for Butyrylcholinesterase
JF - Polymers
N2 - Molecularly imprinted polymers (MIPs) mimic the binding sites of antibodies by substituting the amino acid-scaffold of proteins by synthetic polymers. In this work, the first MIP for the recognition of the diagnostically relevant enzyme butyrylcholinesterase (BuChE) is presented. The MIP was prepared using electropolymerization of the functional monomer o-phenylenediamine and was deposited as a thin film on a glassy carbon electrode by oxidative potentiodynamic polymerization. Rebinding and removal of the template were detected by cyclic voltammetry using ferricyanide as a redox marker. Furthermore, the enzymatic activity of BuChE rebound to the MIP was measured via the anodic oxidation of thiocholine, the reaction product of butyrylthiocholine. The response was linear between 50 pM and 2 nM concentrations of BuChE with a detection limit of 14.7 pM. In addition to the high sensitivity for BuChE, the sensor responded towards pseudo-irreversible inhibitors in the lower mM range.
KW - molecularly imprinted polymers
KW - biomimetic sensors
KW - butyrylcholinesterase
KW - o-phenylenediamine
KW - rivastigmine
Y1 - 2019
U6 - https://doi.org/10.3390/polym11121970
SN - 2073-4360
VL - 11
IS - 12
PB - MDPI
CY - Basel
ER -